Factors affecting treatment outcomes in patients with oral lichen planus lesions: a retrospective study of 113 cases
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Oral lichen planus (OLP) is a chronic oral mucosal disease that has been recognized as an immune condition. The purpose of this study was to evaluate factors affecting the clinical outcomes of topical corticosteroid application on OLP lesions using dexamethasone gargle and ointment. Methods: The charts of patients who were clinically diagnosed with OLP and treated with dexamethasone from July 2003 to August 2017 at the Section of Dentistry of Seoul National University Bundang Hospital were thoroughly evaluated to identify subjects who were suitable for this retrospective study. For each patient, age at the index date, gender, medical history, and dental records related to OLP lesions and dexamethasone treatment were reviewed. Results: In total, 113 of the 225 patients were included in the present study. Among them, 79 patients were female (69.9%) and 34 were male (30.1%), with a mean age of 57.6 years. The average duration of dexamethasone treatment was 4.7 months and the mean follow-up period was 2.24 years. Improvements were observed within 1 year after dexamethasone treatment in most cases, and 17.7% of patients had a new OLP lesion after treatment. New OLP lesions were more frequently gingival than mucosal, although mucosal OLP lesions were more common than gingival OLP lesions in all age groups. In age- and gender-adjusted multivariate logistic regression, a history of malignant disease was found to be a significant factor affecting the formation of new lesions. Gingival OLP lesions and intermittent use of dexamethasone showed near-significant associations. In Kaplan-Meier failure analysis, history of malignancy, menopausal status, age, and the site of the OLP lesion were significant factors affecting clinical outcomes. Conclusions: The treatment outcomes of OLP were significantly influenced by age, history of malignancy, menopausal status, and the site of the OLP lesion, but not by factors related to dexamethasone treatment.
Abstract
Purpose: Oral lichen planus (OLP) is a chronic oral mucosal disease that has been recognized as an immune condition. The purpose of this study was to evaluate factors affecting the clinical outcomes of topical corticosteroid application on OLP lesions using dexamethasone gargle and ointment. Methods: The charts of patients who were clinically diagnosed with OLP and treated with dexamethasone from July 2003 to August 2017 at the Section of Dentistry of Seoul National University Bundang Hospital were thoroughly evaluated to identify subjects who were suitable for this retrospective study. For each patient, age at the index date, gender, medical history, and dental records related to OLP lesions and dexamethasone treatment were reviewed. Results: In total, 113 of the 225 patients were included in the present study. Among them, 79 patients were female (69.9%) and 34 were male (30.1%), with a mean age of 57.6 years. The average duration of dexamethasone treatment was 4.7 months and the mean follow-up period was 2.24 years. Improvements were observed within 1 year after dexamethasone treatment in most cases, and 17.7% of patients had a new OLP lesion after treatment. New OLP lesions were more frequently gingival than mucosal, although mucosal OLP lesions were more common than gingival OLP lesions in all age groups. In age- and gender-adjusted multivariate logistic regression, a history of malignant disease was found to be a significant factor affecting the formation of new lesions. Gingival OLP lesions and intermittent use of dexamethasone showed near-significant associations. In Kaplan-Meier failure analysis, history of malignancy, menopausal status, age, and the site of the OLP lesion were significant factors affecting clinical outcomes. Conclusions: The treatment outcomes of OLP were significantly influenced by age, history of malignancy, menopausal status, and the site of the OLP lesion, but not by factors related to dexamethasone treatment.
참고문헌 (28)
- Alrashdan MS, "Oral lichen planus: a literature review and update", Arch Dermatol Res, 308, pp.539~551 (2016)
- McCartan BE, "The reported prevalence of oral lichen planus: a review and critique", J Oral Pathol Med, 37, pp.447~453 (2008)
- Kurago ZB, "Etiology and pathogenesis of oral lichen planus: an overview", Oral Surg Oral Med Oral Pathol Oral Radiol, 122, pp.72~80 (2016)
- Dissemond J, "Oral lichen planus: an overview", J Dermatolog Treat, 15, pp.136~140 (2004)
- Naylor GD, "Treating erosive lichen planus with griseofulvin: a report of four cases", Quintessence Int, 21, pp.943~947 (1990)
- Carrozzo M, "The management of oral lichen planus", Oral Dis, 5, pp.196~205 (1999)
- McCreary CE, "Clinical management of oral lichen planus", Br J Oral Maxillofac Surg, 37, pp.338~343 (1999)
- Scully C, "Update on oral lichen planus: etiopathogenesis and management", Crit Rev Oral Biol Med, 9, pp.86~122 (1998)
- Hambly JL, "Comparison between self-formulation and compounded-formulation dexamethasone mouth rinse for oral lichen planus: a pilot, randomized, cross-over trial", J Investig Clin Dent, 8, pp.e12225~ (2017)
- Pedersen A, "Glucocorticosteroids and oral medicine", J Oral Pathol, 13, pp.1~15 (1984)
- Roopashree MR, "Pathogenesis of oral lichen planus--a review", J Oral Pathol Med, 39, pp.729~734 (2010)
- Singh N, "Oral complications of cancer therapies: prevention and management", Clin Oncol (R Coll Radiol), 8, pp.15~24 (1996)
- Lockhart PB, "Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study", J Dermatol Surg Oncol, 7, pp.1019~1025 (1981)
- Lamey PJ, "Grinspan's syndrome: a drug-induced phenomenon?", Oral Surg Oral Med Oral Pathol, 70, pp.184~185 (1990)
- Lavaee F, "Evaluation of the association between oral lichen planus and hypothyroidism: a retrospective comparative study", J Dent (Shiraz), 17, pp.38~42 (2016)
- Li D, "The association of thyroid disease and oral lichen planus: a literature review and meta-analysis", Front Endocrinol (Lausanne), 8, pp.310~ (2017)
- Eisen D., "The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients", J Am Acad Dermatol, 46, pp.207~214 (2002)
- Scully C, "Lichen planus: review and update on pathogenesis", J Oral Pathol, 14, pp.431~458 (1985)
- Mignogna MD, "Gingival involvement of oral lichen planus in a series of 700 patients", J Clin Periodontol, 32, pp.1029~1033 (2005)
- Holmstrup P, "Effect of dental plaque control on gingival lichen planus", Oral Surg Oral Med Oral Pathol, 69, pp.585~590 (1990)
- Guiglia R, "A combined treatment regimen for desquamative gingivitis in patients with oral lichen planus", J Oral Pathol Med, 36, pp.110~116 (2007)
- López-Jornet P, "Application of a motivation-behavioral skills protocol in gingival lichen planus: a short-term study", J Periodontol, 81, pp.1449~1454 (2010)
- Petersilka GJ, "Non-interventional study to collect data for the application of lidocaine gel 2% during scaling and root planing and professional mechanical plaque removal", Clin Oral Investig (2018)
- Al-Hashimi I, "Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, pp.S25~ (2007)
- van der Meij EH, "The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 96, pp.164~171 (2003)
- Fitzpatrick SG, "The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review", J Am Dent Assoc, 145, pp.45~56 (2014)
- Cheng YS, "Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology", Oral Surg Oral Med Oral Pathol Oral Radiol, 122, pp.332~354 (2016)
- Gonzalez-Moles MA, "Oral lichen planus: controversies surrounding malignant transformation", Oral Dis, 14, pp.229~243 (2008)